Suppr超能文献

铜绿假单胞菌中抗菌药物耐药性的产生与持续存在:对机械通气患者的纵向观察

Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.

作者信息

Reinhardt Anita, Köhler Thilo, Wood Paul, Rohner Peter, Dumas Jean-Luc, Ricou Bara, van Delden Christian

机构信息

Département de Microbiologie et de Médecine Moléculaire, Centre Médical Universitaire de Genève, and Laboratoire Central de Bactériologie, Service des Soins Intensifs, Hôpital Universitaire de Genève, Geneva, Switzerland.

出版信息

Antimicrob Agents Chemother. 2007 Apr;51(4):1341-50. doi: 10.1128/AAC.01278-06. Epub 2007 Jan 29.

Abstract

Intubated patients frequently become colonized by Pseudomonas aeruginosa, which is subsequently responsible for ventilator-associated pneumonia. This pathogen readily acquires resistance against available antimicrobials. Depending on the resistance mechanism selected for, resistance might either be lost or persist after removal of the selective pressure. We investigated the rapidity of selection, as well as the persistence, of antimicrobial resistance and determined the underlying mechanisms. We selected 109 prospectively collected P. aeruginosa tracheal isolates from two patients based on their prolonged intubation and colonization periods, during which they had received carbapenem, fluoroquinolone (FQ), or combined beta-lactam-aminoglycoside therapies. We determined antimicrobial resistance phenotypes by susceptibility testing and used quantitative real-time PCR to measure the expression of resistance determinants. Within 10 days after the initiation of therapy, all treatment regimens selected resistant isolates. Resistance to beta-lactam and FQ was correlated with ampC and mexC gene expression levels, respectively, whereas imipenem resistance was attributable to decreased oprD expression. Combined beta-lactam-aminoglycoside resistance was associated with the appearance of small-colony variants. Imipenem and FQ resistance persisted for prolonged times once the selecting antimicrobial treatment had been discontinued. In contrast, resistance to beta-lactams disappeared rapidly after removal of the selective pressure, to reappear promptly upon renewed exposure. Our results suggest that resistant P. aeruginosa is selected in less than 10 days independently of the antimicrobial class. Different resistance mechanisms lead to the loss or persistence of resistance after the removal of the selecting agent. Even if resistant isolates are not evident upon culture, they may persist in the lung and can be rapidly reselected.

摘要

气管插管患者常被铜绿假单胞菌定植,随后该菌会引发呼吸机相关性肺炎。这种病原体很容易获得对现有抗菌药物的耐药性。根据所选择的耐药机制,在去除选择压力后,耐药性可能会消失或持续存在。我们研究了抗菌药物耐药性的选择速度以及持续性,并确定了其潜在机制。我们基于两名患者较长的插管和定植期,前瞻性收集了109株铜绿假单胞菌气管分离株,在此期间他们接受了碳青霉烯类、氟喹诺酮(FQ)或β-内酰胺类-氨基糖苷类联合治疗。我们通过药敏试验确定抗菌药物耐药表型,并使用定量实时PCR测量耐药决定子的表达。在治疗开始后的10天内,所有治疗方案都选择出了耐药菌株。对β-内酰胺类和FQ的耐药性分别与ampC和mexC基因表达水平相关,而亚胺培南耐药性归因于oprD表达降低。β-内酰胺类-氨基糖苷类联合耐药性与小菌落变体的出现有关。一旦停止选择抗菌治疗,亚胺培南和FQ耐药性会持续较长时间。相比之下,去除选择压力后,对β-内酰胺类的耐药性迅速消失,再次接触后又会迅速重新出现。我们的结果表明,无论抗菌药物类别如何,耐药铜绿假单胞菌在不到10天内即可被选择出来。不同的耐药机制导致在去除选择剂后耐药性的丧失或持续存在。即使培养时未发现耐药菌株,它们也可能在肺部持续存在并可迅速重新被选择出来。

相似文献

1
6
Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
J Antimicrob Chemother. 2013 Aug;68(8):1763-71. doi: 10.1093/jac/dkt115. Epub 2013 Apr 29.
8
Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
Pathol Biol (Paris). 2009 Nov-Dec;57(7-8):530-5. doi: 10.1016/j.patbio.2008.09.001. Epub 2008 Oct 31.
9
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
J Antimicrob Chemother. 2011 Sep;66(9):2022-7. doi: 10.1093/jac/dkr232. Epub 2011 Jun 8.

引用本文的文献

2
Repeat gram-negative hospital-acquired infections and antibiotic susceptibility: A systematic review.
J Infect Public Health. 2018 Jul-Aug;11(4):455-462. doi: 10.1016/j.jiph.2017.09.024. Epub 2017 Oct 20.
3
Risk of drug resistance in repeat gram-negative infections among patients with multiple hospitalizations.
J Crit Care. 2018 Feb;43:260-264. doi: 10.1016/j.jcrc.2017.09.033. Epub 2017 Sep 18.
4
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01589-17. Print 2017 Nov.
5
Structural insights into the regulatory mechanism of the Pseudomonas aeruginosa YfiBNR system.
Protein Cell. 2016 Jun;7(6):403-16. doi: 10.1007/s13238-016-0264-7. Epub 2016 Apr 25.
6
Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs.
Infect Drug Resist. 2015 Jul 29;8:237-47. doi: 10.2147/IDR.S68214. eCollection 2015.
7
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
Clin Microbiol Rev. 2015 Apr;28(2):337-418. doi: 10.1128/CMR.00117-14.
8
BdlA, DipA and induced dispersion contribute to acute virulence and chronic persistence of Pseudomonas aeruginosa.
PLoS Pathog. 2014 Jun 5;10(6):e1004168. doi: 10.1371/journal.ppat.1004168. eCollection 2014 Jun.
9
Overexpression of MexCD-OprJ reduces Pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing.
Antimicrob Agents Chemother. 2014;58(4):2426-9. doi: 10.1128/AAC.02012-13. Epub 2014 Jan 13.
10
Investigating the allosteric regulation of YfiN from Pseudomonas aeruginosa: clues from the structure of the catalytic domain.
PLoS One. 2013 Nov 22;8(11):e81324. doi: 10.1371/journal.pone.0081324. eCollection 2013.

本文引用的文献

2
Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2006 Apr;50(4):1347-51. doi: 10.1128/AAC.50.4.1347-1351.2006.
3
Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR.
FEMS Microbiol Lett. 2006 Jan;254(2):217-25. doi: 10.1111/j.1574-6968.2005.00008.x.
5
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.
Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416. doi: 10.1164/rccm.200405-644ST.
6
Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance.
FEMS Microbiol Lett. 2004 Jul 1;236(1):137-43. doi: 10.1016/j.femsle.2004.05.039.
8
Nosocomial pneumonia in the intensive care unit: controversies and dilemmas.
J Intensive Care Med. 2003 Jul-Aug;18(4):175-88. doi: 10.1177/0885066603254249.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验